公开(公告)号：US20060228379A1

公开(公告)日：2006-10-12

申请号：US11450452

申请日：2006-06-12

申请人： Chang Won Choi ,  Mi Hyoun Park ,  Sang Ho Hwang ,  Suk Gyu Woo ,  Mi Kyung Song ,  Jong Jun Im ,  Sung Gil Hong ,  Joong Hark Kim ,  Jung Soon Jang ,  Hwa Young Kim

发明人： Chang Won Choi ,  Mi Hyoun Park ,  Sang Ho Hwang ,  Suk Gyu Woo ,  Mi Kyung Song ,  Jong Jun Im ,  Sung Gil Hong ,  Joong Hark Kim ,  Jung Soon Jang ,  Hwa Young Kim

IPC分类号： A61K39/02 ,  A61K35/74 ,  C12N1/20

CPC分类号： C12R1/01 ,  A23K10/12 ,  A23K10/18 ,  A23K30/18 ,  A23K40/20 ,  A23K40/25 ,  A23L3/3571 ,  A23L33/135 ,  A23Y2280/55 ,  A61K2035/11 ,  C12N1/20 ,  Y10S435/822

摘要： The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune enhancement, anticancer and antiviral activities and a use thereof. Due to its excellent immune enhancement, anticancer and antimicrobial activities by activating macrophages/spleen cells and inducing gut immunity, the Pediococcus pentosaceus EROM101 of the present invention can be effectively used for the production of various products such as immune enhancement agent, anticancer agent, antimicrobial agent, food additive, intestinal function-controlling agent, live bacterial agent, feed additive and other fermented products.

摘要翻译： 本发明涉及一种新型的小球菌属微生物，更具体地说是源于具有免疫增强，抗癌和抗病毒活性的人肠道的戊糖片球菌EROM101（KCCM-10517）及其用途。 由于其通过激活巨噬细胞/脾细胞和诱导肠道免疫的优异的免疫增强，抗癌和抗微生物活性，本发明的戊糖片球菌EROM101可以有效地用于生产各种产品，如免疫增强剂，抗癌剂，抗微生物剂 药剂，食品添加剂，肠功能控制剂，活细菌剂，饲料添加剂等发酵产品。

公开(公告)号：US07241441B2

公开(公告)日：2007-07-10

申请号：US11450452

申请日：2006-06-12

申请人： Chang Won Choi ,  Mi Hyoun Park ,  Sang Ho Hwang ,  Suk Gyu Woo ,  Mi Kyung Song ,  Jong Jun Im ,  Sung Gil Hong ,  Joong Hark Kim ,  Jung Soon Jang ,  Hwa Young Kim

发明人： Chang Won Choi ,  Mi Hyoun Park ,  Sang Ho Hwang ,  Suk Gyu Woo ,  Mi Kyung Song ,  Jong Jun Im ,  Sung Gil Hong ,  Joong Hark Kim ,  Jung Soon Jang ,  Hwa Young Kim

IPC分类号： A01N63/00 ,  A01N65/00 ,  C12N1/20 ,  A61K39/02

CPC分类号： C12R1/01 ,  A23K10/12 ,  A23K10/18 ,  A23K30/18 ,  A23K40/20 ,  A23K40/25 ,  A23L3/3571 ,  A23L33/135 ,  A23Y2280/55 ,  A61K2035/11 ,  C12N1/20 ,  Y10S435/822

摘要： The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune enhancement, anticancer and antiviral activities and a use thereof. Due to its excellent immune enhancement, anticancer and antimicrobial activities by activating macrophages/spleen cells and inducing gut immunity, the Pediococcus pentosaceus EROM101 of the present invention can be effectively used for the production of various products such as immune enhancement agent, anticancer agent, antimicrobial agent, food additive, intestinal function-controlling agent, live bacterial agent, feed additive and other fermented products.

摘要翻译： 本发明涉及一种新型的小球菌属微生物，更具体地说是源于具有免疫增强，抗癌和抗病毒活性的人肠道的戊糖片球菌EROM101（KCCM-10517）及其用途。 由于其通过激活巨噬细胞/脾细胞和诱导肠道免疫的优异的免疫增强，抗癌和抗微生物活性，本发明的戊糖片球菌EROM101可以有效地用于生产各种产品，如免疫增强剂，抗癌剂，抗微生物剂 药剂，食品添加剂，肠功能控制剂，活细菌剂，饲料添加剂等发酵产品。